RMR vs ADAG Comparison

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company with a primary focus on commercial real estate and related businesses in the United States. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. The company manages a diverse portfolio of real estate assets across sectors such as office, industrial, healthcare, retail, and hospitality, etc. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company derives the majority of its revenues from its provision of management services.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.